Celtaxsys Inc Atlanta, GA - 30332

Celtaxsys Inc is categorized under Commercial Medical Research in Atlanta, GA and active since 2005.

Celtaxsys Inc was established in 2005, and today employs 1 to 4, earning $20.000.000 to $49.9999.999 per year. This is a Commercial Medical Research business, which does work in the B2B market, and is classified as a Commercial Medical Research, under code number 3254120 by the NAICS.

If you are seeking more information, feel free to contact Michael Hanley, Chief Executive Officer at the company’s single location by writing to 311 Ferst Drive, Atlanta, Georgia GA 30332 or by phoning (404) 920-0700. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.

Business Name: Celtaxsys Inc
Contact Person: Michael Hanley, Chief Executive Officer
Address: 311 Ferst Drive, Atlanta, Georgia 30332
Phone Number: (404) 920-0700
Website Address: celtaxsys.com
Annual Revenue (USD): $20.000.000 to $49.9999.999
Founded: 2005
Location Type: Single Location
Employee Number: 1 to 4
Business Type: B2B (Business to Business)
Business Category: Commercial Medical Research
SIC Code: 8731
NAICS Code: 3254120
Share This Business:

Celtaxsys Inc was started in 2005 to provide professional Commercial Medical Research under the SIC code 8731 and NAICS code 3254120. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $20.000.000 to $49.9999.999 per annum.

Feel free to contact Michael Hanley, Chief Executive Officer for inquiries that concern Celtaxsys Inc by calling the company number (404) 920-0700, as your correspondence is most welcome. Additionally, the physical location of the single location of Celtaxsys Inc can be found at the coordinates 33.77116,-84.38006 as well as the street address 311 Ferst Drive in Atlanta, Georgia 30332.

For its online presence, you may visit Celtaxsys Inc’s website at celtaxsys.com and engage with its social media outlets through on Twitter and on Facebook.